Comparison of Direct Oral Anticoagulants for Acute Hospital Mortality in Venous Thromboembolism.

Yuichiro OkushiKenya KusunoseMichikazu NakaiYoko SumitaTakayuki IseKoji YamaguchiShusuke YagiDaiju FukudaHirotsugu YamadaTakeshi SoekiTetsuzo WakatsukiMasataka Sata

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)

On PS-matched analysis, there was a difference in in-hospital mortality, especially in the rivaroxaban and apixaban group. Identifying the clinical characteristics of patients associated with each DOAC, as well as prognosis, will be useful in determining treatment strategies for VTE.

Keyphrases

venous thromboembolism
direct oral anticoagulants
end stage renal disease
atrial fibrillation
newly diagnosed
ejection fraction
healthcare
liver failure
peritoneal dialysis
cardiovascular events
coronary artery disease
patient reported outcomes
patient reported
hepatitis b virus